Compare the above results to those of nattokinase which yielded benefit in over 70% depending on dosing/formulation. NK, curcumin & quercetin all had similar sample size (n=157-178).
— LongCovidPharmD (@organichemusic) October 15, 2022
Q: Did formulation affect efficacy in quercetin as it may in NK?https://t.co/nxlA8SDrNs
Saturday, October 15, 2022
nattokinase . . . yielded benefit in over 70%
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment